Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-3.88x - 0.1x1.32x - -2.11x - 513M
42.6x6.68x2.08x9.96x35.95x36.66x0.03% 44.74B
15.63x3.78x0.2x5.59x12.3x13.44x1.91% 39.46B
-53.22x92.93x0.92x17.93x-59.23x-58.41x-.--% 30.85B
-25.8x1.19x-1.11x4.23x-11.67x-9.29x-.--% 25.64B
27.29x2.67x0.58x5.62x15.61x19.3x-.--% 18.74B
21.64x2.54x-1.21x4.48x15.61x16.63x-.--% 16.45B
-298.93x10.73x6.11x24.74x1362.16x-298.81x-.--% 12.22B
-13.89x60.8x0.67x6208.56x-17.75x-13.4x-.--% 12.19B
-158.7x17.53x-1.84x38.79x-154.09x-140.56x-.--% 11.33B
13.85x3.57x1.38x3.86x9.15x10.3x-.--% 11B
-87.03x16.44x1.42x6.33x-94.56x-65.6x-.--% 9.94B
-30.73x - 1.11x - - - - 8.69B
-8.03x - -0.26x - -7.12x-6.91x-.--% 8.54B
-17.55x15.8x-0x16.97x-24.13x-17x-.--% 8.5B
33.32x6.33x0.7x9.68x23.99x24.97x0.25% 7.77B
-18x6.12x6.34x509.43x-15.72x-15.88x-.--% 8.04B
-207.41x16.34x2.39x18.53x329.85x-420.1x-.--% 7.72B
Average -42.71x 17.56x 1.09x 430.38x 88.77x -54.52x 0.14% 15.68B
Weighted average by Cap. -25.57x 19.16x 0.94x 311.17x 61.12x -31.28x 0.29%
Bio Therapeutic Drugs
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW